Zai Lab Analyst Price Targets - Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD83,546.81+0.75%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Zai Lab Ltd

ZLABNASDAQ

Trade with Public

Trade with Public

$24.99

0.180.73%

Last update: Oct 9, 4:00 PM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Zai Lab Analyst Price Targets - Benzinga

Zai Lab Analyst Price Targets

Wall Street analyst price targets and consensus rating for Zai Lab (ZLAB).

Price Target Range — 10 Quarters

Analyst Consensus — 8 Analysts

7Buy

1Hold

Consensus RatingOverweight# Analysts8Avg. Consensus PT$48Upside to Avg. PT+93.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 7, 2026	Citigroup	Yigal Nochomovitz	PT Raise	Buy	$44→$45
May 8, 2026	Citigroup	Yigal Nochomovitz	PT Cut	Buy	$47→$44
Mar 18, 2026	JP Morgan	Anupam Rama	PT Cut	Overweight	$39→$32
Feb 27, 2026	Cantor Fitzgerald	Li Watsek	PT Cut	Overweight	$55→$37
Feb 5, 2026	JP Morgan	Anupam Rama	PT Cut	Overweight	$46→$39
Jan 7, 2026	UBS	Michael Yee	Initiate	Buy	$35
Aug 11, 2025	Citigroup	Yigal Nochomovitz	PT Raise	Buy	$66→$69
Jun 30, 2025	Leerink Partners	Jonathan Chang	PT Raise	Outperform	$73→$75
Mar 27, 2025	Cantor Fitzgerald	Li Watsek	Maintained	Overweight	—
Mar 13, 2025	JP Morgan	Anupam Rama	PT Raise	Overweight	$44→$51
Mar 7, 2025	Scotiabank	Louise Chen	Initiate	Sector Outperform	$55
Mar 3, 2025	B of A Securities	David Lim	Downgrade	Buy→Neutral	$29→$36
Oct 25, 2024	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—
Oct 21, 2024	JP Morgan	Anupam Rama	PT Raise	Overweight	$38→$44
Aug 7, 2024	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—
Jul 12, 2024	JP Morgan	Anupam Rama	PT Cut	Overweight	$43→$38
Jul 1, 2024	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—
Jun 25, 2024	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—
Feb 29, 2024	Citigroup	Yigal Nochomovitz	PT Cut	Buy	$123→$66
Dec 14, 2023	Morgan Stanley	Jack Lin	Initiate	Overweight	$48

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Citigroup Maintains Buy on Zai Lab, Raises Price Target to $45

Citigroup analyst Yigal Nochomovitz maintains Zai Lab (NASDAQ:ZLAB) with a Buy and raises the price target from $44 to $45.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Zai Lab, Lowers Price Target to $44

Citigroup analyst Yigal Nochomovitz maintains Zai Lab (NASDAQ:ZLAB) with a Buy and lowers the price target from $47 to $44.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Zai Lab, Lowers Price Target to $32

JP Morgan analyst Anupam Rama maintains Zai Lab (NASDAQ:ZLAB) with a Overweight and lowers the price target from $39 to $32.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Maintains Overweight on Zai Lab, Lowers Price Target to $37

Cantor Fitzgerald analyst Li Watsek maintains Zai Lab (NASDAQ:ZLAB) with a Overweight and lowers the price target from $55 to $37.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Zai Lab, Lowers Price Target to $39

JP Morgan analyst Anupam Rama maintains Zai Lab (NASDAQ:ZLAB) with a Overweight and lowers the price target from $46 to $39.

Benzinga Newsdesk

PRO
UBS Initiates Coverage On Zai Lab with Buy Rating, Announces Price Target of $35

UBS analyst Michael Yee initiates coverage on Zai Lab (NASDAQ:ZLAB) with a Buy rating and announces Price Target of $35.

Benzinga Newsdesk